Celgene Corp (CELG) 107.09 $CELG
'Fast Money' Recap: Will Japan's Stimulus Lead to U.S. Deflation?
at The Street - Sat Nov 01, 4:00AM CDT
The trading panel discussed the S&P 500, whether to buy Apple and if Kim Kardasian is the only thing Glu Mobile has going for it.
FDX: 167.40 (+2.11), HD: 97.52 (unch), C: 53.53 (+0.38), SNE: 19.82 (+1.10), BBY: 34.14 (+0.52), GLUU: 3.87 (+0.26), CELG: 107.09 (+0.15), DXJ: 53.82 (+3.33), SBUX: 75.56 (-1.76), GS: 189.99 (+3.02), EXPE: 84.97 (+4.24), AAPL: 108.00 (+1.02), CTRL: 15.51 (+1.84)
IBD 50 Caps Impressive 2-Week Rally
at Investor's Business Daily - Fri Oct 31, 5:47PM CDT
The IBD 50 just capped its best two-week performance in more than three years -- a run that's produced a batch of breakouts. The index rallied 9.4% over the past two weeks. That's the best two-week period since July 2011, when the IBD 50 roared...
ODFL: 72.87 (+0.51), AAP: 146.96 (+1.25), AKRX: 44.55 (+0.91), ILMN: 192.58 (-0.84), NXPI: 68.66 (+3.25), CDW: 30.84 (+0.71), CELG: 107.09 (+0.15), BIDU: 238.77 (+1.76), GILD: 112.00 (-2.22), JAZZ: 168.84 (-0.98), FLT: 150.56 (+8.01), FL: 56.01 (+0.16), AAPL: 108.00 (+1.02), AVGO: 86.25 (+3.86)
Final Glance: Biotechnology companies
AP - Fri Oct 31, 5:04PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 112.00 (-2.22), AMGN: 162.18 (+0.60), CELG: 107.09 (+0.15)
Midday Glance: Biotechnology companies
AP - Fri Oct 31, 1:49PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 112.00 (-2.22), AMGN: 162.18 (+0.60), CELG: 107.09 (+0.15)
Early Glance: Biotechnology companies
AP - Fri Oct 31, 11:28AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
GILD: 112.00 (-2.22), AMGN: 162.18 (+0.60), CELG: 107.09 (+0.15)
Celgene Corporation to Webcast at Upcoming Investor Conferences and Medical Congress
Business Wire - Fri Oct 31, 7:30AM CDT
Celgene Corporation (NASDAQ:CELG) plans to present at two upcoming investor conferences, where Celgene management will provide an overview of the Company, and at the 56th American Society of Hematology (ASH) annual meeting in December. The conferences and ASH event will be webcast live and the webcast will be available in the Investor Relations section of the Company's website at www.celgene.com.
CELG: 107.09 (+0.15), CELGZ: 3.61 (+0.06)
Jim Cramer's Top Stock Picks: CELG REGN GILD BIIB TTWO CRL FLEX
at The Street - Fri Oct 31, 5:00AM CDT
Cramer says Take-Two Interactive is king of the hill and he's a big fan of Flextronics and its stock buyback program.
FLEX: 10.72 (+0.46), TTWO: 26.45 (+1.18), BIIB: 321.08 (+0.08), GILD: 112.00 (-2.22), CRL: 63.16 (+0.35), REGN: 393.72 (+0.92), CELG: 107.09 (+0.15)
Jim Cramer's 'Mad Money' Recap: Here's Why the Bears Were Dead Wrong
at The Street - Thu Oct 30, 7:11PM CDT
The end of quantitative easing was supposed to create a laundry list of problems, Cramer says. It didn't happen.
MMM: 153.77 (+1.67), BIIB: 321.08 (+0.08), HON: 96.12 (+0.53), FB: 74.99 (+0.88), BMY: 58.19 (-0.79), MGM: 23.25 (+0.27), ATK: 116.96 (+6.77), YRCW: 21.44 (+3.24), UPS: 104.91 (+1.62), SLB: 98.66 (+1.04), CELG: 107.09 (+0.15), WPRT: 6.17 (+0.12), SBUX: 75.56 (-1.76), TTWO: 26.45 (+1.18), DO: 37.71 (-0.94), ETP: 64.43 (+0.41), GILD: 112.00 (-2.22), ARR: 3.96 (-0.01), CMG: 638.00 (-1.68), MPEL: 27.14 (+0.78), WNC: 10.30 (+0.81), CRL: 63.16 (+0.35), AAPL: 108.00 (+1.02), REGN: 393.72 (+0.92)
5 Things Bristol-Myers Squibb Co.'s Management Wants You to Know
George Budwell, The Motley Fool - Motley Fool - Thu Oct 30, 10:18AM CDT
Like most of its Big Pharma peers, Bristol-Myers Squibb is undergoing major changes due to the patent cliff. Per its latest earnings report , for instance, the company saw third-quarter revenue drop by 4% to $3.92 billion, year over year, mostly...
GILD: 112.00 (-2.22), AZN: 72.94 (+0.34), BMY: 58.19 (-0.79), NVS: 92.69 (+0.74), CELG: 107.09 (+0.15)
'Mad Money' Lightning Round: Stay Away From Applied Materials
at The Street - Thu Oct 30, 5:00AM CDT
Cramer prefers Isis Pharmaceuticals to Pfizer and Kinder Morgan to El Paso Pipeline Partners.
KMI: 38.70 (+0.16), EPB: 40.65 (+0.10), ISIS: 46.06 (+0.18), PFE: 29.95 (+0.11), AMAT: 22.09 (+0.75), INVN: 16.21 (+0.54), IGT: 16.39 (+0.20), REGN: 393.72 (+0.92), CVRR: 24.24 (-0.10), CELG: 107.09 (+0.15)
Jim Cramer's 'Mad Money' Recap: Where to Find Bargains Created by the Fed
at The Street - Wed Oct 29, 7:12PM CDT
With the Federal Reserve finally ending its bond buying, there are many stocks that are ready to be bought, not sold, on any Fed-induced weakness, Cramer says.
KMI: 38.70 (+0.16), ETN: 68.39 (+1.62), FB: 74.99 (+0.88), PFE: 29.95 (+0.11), INVN: 16.21 (+0.54), WDC: 98.37 (+3.18), HPQ: 35.88 (+0.56), CVRR: 24.24 (-0.10), CELG: 107.09 (+0.15), EPB: 40.65 (+0.10), ISIS: 46.06 (+0.18), IBM: 164.40 (+0.05), AMAT: 22.09 (+0.75), GOOGL: 567.87 (+7.60), TWTR: 41.47 (-0.33), MSFT: 46.95 (+0.90), IGT: 16.39 (+0.20), REGN: 393.72 (+0.92), PII: 150.86 (+2.30), BABA: 98.60 (-0.13)
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Oct 29, 11:28AM CDT
Quite a few biotech companies fared well i the third quarter with earnings surpassing expectations and guidance being raised.
BIIB: 321.08 (+0.08), CBST: 72.29 (-0.21), MDCO: 25.32 (-0.34), SRPT: 16.17 (+0.44), ALXN: 191.36 (-1.57), AMGN: 162.18 (+0.60), CELG: 107.09 (+0.15)
SmarTrend Watching for Potential Pullback in Shares of Celgene After 2.54% Gain
Comtex SmarTrend(R) - Tue Oct 28, 3:59PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $104.06 to a high of $106.07. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $103.91 on volume of 6.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 107.09 (+0.15)
After Yesterday's Rally of 2.54% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Oct 28, 3:58PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $104.06 to a high of $106.07. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $103.91 on volume of 6.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 107.09 (+0.15)
'Fast Money' Recap: Will Japan's Stimulus Lead to U.S. Deflation?
at The Street - Sat Nov 01, 4:00AM CDT
The trading panel discussed the S&P 500, whether to buy Apple and if Kim Kardasian is the only thing Glu Mobile has going for it.
FDX: 167.40 (+2.11), HD: 97.52 (unch), C: 53.53 (+0.38), SNE: 19.82 (+1.10), BBY: 34.14 (+0.52), GLUU: 3.87 (+0.26), CELG: 107.09 (+0.15), DXJ: 53.82 (+3.33), SBUX: 75.56 (-1.76), GS: 189.99 (+3.02), EXPE: 84.97 (+4.24), AAPL: 108.00 (+1.02), CTRL: 15.51 (+1.84)
IBD 50 Caps Impressive 2-Week Rally
at Investor's Business Daily - Fri Oct 31, 5:47PM CDT
The IBD 50 just capped its best two-week performance in more than three years -- a run that's produced a batch of breakouts. The index rallied 9.4% over the past two weeks. That's the best two-week period since July 2011, when the IBD 50 roared...
ODFL: 72.87 (+0.51), AAP: 146.96 (+1.25), AKRX: 44.55 (+0.91), ILMN: 192.58 (-0.84), NXPI: 68.66 (+3.25), CDW: 30.84 (+0.71), CELG: 107.09 (+0.15), BIDU: 238.77 (+1.76), GILD: 112.00 (-2.22), JAZZ: 168.84 (-0.98), FLT: 150.56 (+8.01), FL: 56.01 (+0.16), AAPL: 108.00 (+1.02), AVGO: 86.25 (+3.86)
Final Glance: Biotechnology companies
AP - Fri Oct 31, 5:04PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 112.00 (-2.22), AMGN: 162.18 (+0.60), CELG: 107.09 (+0.15)
Midday Glance: Biotechnology companies
AP - Fri Oct 31, 1:49PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 112.00 (-2.22), AMGN: 162.18 (+0.60), CELG: 107.09 (+0.15)
Early Glance: Biotechnology companies
AP - Fri Oct 31, 11:28AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
GILD: 112.00 (-2.22), AMGN: 162.18 (+0.60), CELG: 107.09 (+0.15)
Celgene Corporation to Webcast at Upcoming Investor Conferences and Medical Congress
Business Wire - Fri Oct 31, 7:30AM CDT
Celgene Corporation (NASDAQ:CELG) plans to present at two upcoming investor conferences, where Celgene management will provide an overview of the Company, and at the 56th American Society of Hematology (ASH) annual meeting in December. The conferences and ASH event will be webcast live and the webcast will be available in the Investor Relations section of the Company's website at www.celgene.com.
CELG: 107.09 (+0.15), CELGZ: 3.61 (+0.06)
Jim Cramer's Top Stock Picks: CELG REGN GILD BIIB TTWO CRL FLEX
at The Street - Fri Oct 31, 5:00AM CDT
Cramer says Take-Two Interactive is king of the hill and he's a big fan of Flextronics and its stock buyback program.
FLEX: 10.72 (+0.46), TTWO: 26.45 (+1.18), BIIB: 321.08 (+0.08), GILD: 112.00 (-2.22), CRL: 63.16 (+0.35), REGN: 393.72 (+0.92), CELG: 107.09 (+0.15)
Jim Cramer's 'Mad Money' Recap: Here's Why the Bears Were Dead Wrong
at The Street - Thu Oct 30, 7:11PM CDT
The end of quantitative easing was supposed to create a laundry list of problems, Cramer says. It didn't happen.
MMM: 153.77 (+1.67), BIIB: 321.08 (+0.08), HON: 96.12 (+0.53), FB: 74.99 (+0.88), BMY: 58.19 (-0.79), MGM: 23.25 (+0.27), ATK: 116.96 (+6.77), YRCW: 21.44 (+3.24), UPS: 104.91 (+1.62), SLB: 98.66 (+1.04), CELG: 107.09 (+0.15), WPRT: 6.17 (+0.12), SBUX: 75.56 (-1.76), TTWO: 26.45 (+1.18), DO: 37.71 (-0.94), ETP: 64.43 (+0.41), GILD: 112.00 (-2.22), ARR: 3.96 (-0.01), CMG: 638.00 (-1.68), MPEL: 27.14 (+0.78), WNC: 10.30 (+0.81), CRL: 63.16 (+0.35), AAPL: 108.00 (+1.02), REGN: 393.72 (+0.92)
5 Things Bristol-Myers Squibb Co.'s Management Wants You to Know
George Budwell, The Motley Fool - Motley Fool - Thu Oct 30, 10:18AM CDT
Like most of its Big Pharma peers, Bristol-Myers Squibb is undergoing major changes due to the patent cliff. Per its latest earnings report , for instance, the company saw third-quarter revenue drop by 4% to $3.92 billion, year over year, mostly...
GILD: 112.00 (-2.22), AZN: 72.94 (+0.34), BMY: 58.19 (-0.79), NVS: 92.69 (+0.74), CELG: 107.09 (+0.15)
'Mad Money' Lightning Round: Stay Away From Applied Materials
at The Street - Thu Oct 30, 5:00AM CDT
Cramer prefers Isis Pharmaceuticals to Pfizer and Kinder Morgan to El Paso Pipeline Partners.
KMI: 38.70 (+0.16), EPB: 40.65 (+0.10), ISIS: 46.06 (+0.18), PFE: 29.95 (+0.11), AMAT: 22.09 (+0.75), INVN: 16.21 (+0.54), IGT: 16.39 (+0.20), REGN: 393.72 (+0.92), CVRR: 24.24 (-0.10), CELG: 107.09 (+0.15)
Jim Cramer's 'Mad Money' Recap: Where to Find Bargains Created by the Fed
at The Street - Wed Oct 29, 7:12PM CDT
With the Federal Reserve finally ending its bond buying, there are many stocks that are ready to be bought, not sold, on any Fed-induced weakness, Cramer says.
KMI: 38.70 (+0.16), ETN: 68.39 (+1.62), FB: 74.99 (+0.88), PFE: 29.95 (+0.11), INVN: 16.21 (+0.54), WDC: 98.37 (+3.18), HPQ: 35.88 (+0.56), CVRR: 24.24 (-0.10), CELG: 107.09 (+0.15), EPB: 40.65 (+0.10), ISIS: 46.06 (+0.18), IBM: 164.40 (+0.05), AMAT: 22.09 (+0.75), GOOGL: 567.87 (+7.60), TWTR: 41.47 (-0.33), MSFT: 46.95 (+0.90), IGT: 16.39 (+0.20), REGN: 393.72 (+0.92), PII: 150.86 (+2.30), BABA: 98.60 (-0.13)
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Oct 29, 11:28AM CDT
Quite a few biotech companies fared well i the third quarter with earnings surpassing expectations and guidance being raised.
BIIB: 321.08 (+0.08), CBST: 72.29 (-0.21), MDCO: 25.32 (-0.34), SRPT: 16.17 (+0.44), ALXN: 191.36 (-1.57), AMGN: 162.18 (+0.60), CELG: 107.09 (+0.15)
SmarTrend Watching for Potential Pullback in Shares of Celgene After 2.54% Gain
Comtex SmarTrend(R) - Tue Oct 28, 3:59PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $104.06 to a high of $106.07. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $103.91 on volume of 6.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 107.09 (+0.15)
After Yesterday's Rally of 2.54% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Oct 28, 3:58PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $104.06 to a high of $106.07. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $103.91 on volume of 6.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 107.09 (+0.15)
